NEUROPSYCHIATRIC PRESENTATIONS AND NEUROIMAGING IN PARKINSON’S PLUS SYNDROME: - A THERANOSTIC CONUNDRUM – A CASE REPORT

Article Sidebar

PDF
Published: Sep 1, 2019
Keywords:
Parkinson’s plus syndrome Neuropsychiatry Neuroimaging Differential diagnosis

Main Article Content

SHANTHI. CH
Department of Pharmacology, CVM College of Pharmacy, Velichala, Ramadugu, Karimnagar, Telangana.
RAMA NARSIMHA REDDY A
Department of Pharmacology, CVM College of Pharmacy, Velichala, Ramadugu, Karimnagar, Telangana.
SURESH. A
Department of Psychiatry, Kamineni Institute of Medical Sciences, Narketpally, Nalgonda, Telangana State

Abstract

Parkinson’s plus syndrome is a rare entity, usually a group of heterogeneous degenerative neurological disorders, which differ from the classical idiopathic Parkinson’s disease in certain associated clinical presentations, poor response to levodopa, distinctive pathological characteristics and poor prognosis. Progressive supranuclear palsy (PSP), multiple system atrophy (MSA) and dementia with Lewy body disease (DLB) are commoner disorders. Differential diagnosis and their distinctions is challenging for florid mixed presentations and recent developments in neuroimaging helps provide great deal of insight in resolving these conundrums. We hereby present a rare case of 66 years old longstanding Parkinson’s who presented with overwhelming neuropsychiatric presentations with set of diagnostic challenges at our tertiary care centre.

Downloads

Download data is not yet available.

Article Details

How to Cite
CH, S., REDDY A, R. N., & A, S. (2019). NEUROPSYCHIATRIC PRESENTATIONS AND NEUROIMAGING IN PARKINSON’S PLUS SYNDROME: - A THERANOSTIC CONUNDRUM – A CASE REPORT. Innovat International Journal Of Medical & Pharmaceutical Sciences, 4(5). Retrieved from https://www.innovatpublisher.com/index.php/iijmps/article/view/166
Issue
Vol 4 Issue 5 2019
Section
Original Article(s)

References

Fahn S. Discription of parkinson’s disease as a clinical syndrome. Annals New York Academy Sciences. 2003;991:1-14

Pearce JM. Parkinson’s Disease and its Management. Oxford University Press, Oxford. 1992

Selby G. Cerebral atrophy in parkinsonism. Journal of Neurological Sciences. 1968;6:517-559

Aarsland D, Marsh L, Schrag A. Neuropsychiatric symptoms in Parkinson’s disease

Politis M. Neuroimaging inParkinson’s disease: from research setting to clinical practice. Nature Review Neurology. 2014;10(12):708-722

Marsh L. Neuropsychiatric aspects of Parkinson’s disease. Psychosomatics. 2000;41:15-23

Fenelon G, Mahieux F et al. Hallucinations in Parkinson’s disease: Prevalence, phenomenon and risk factors. Brain. 2000;123:733-745

Ballard C, Holmes C, Mckeith I, Neill D, O’Brien J et al. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer’s disease. Am J Psychiatry. 1999;156(7):1039-45.

McKeith IG, Perry RH, Fairbairn AF, et al. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22:911-2.

Glasmacher S. Saha R. Prognosis in Parkinson plus syndromes – A Systematic review. J of Neurology, Neurosurgery & Psychiatry. 2016;87(12):e1.3-e111. Minati L, Grisoli M, Carella F, De Simone, et al. Imaging Degeneration of the Substantia Nigra in Parkinson Disease with Inversion- Recovery MR Imaging. Am J of Neuroradiology 2007;28(2):309-13.12. Dujardin K, Sockeel P, Devos D, Delliaux M, et al. Characteristics of apathy in Parkinson’s disease. Mov Disord. 2007;22(6):778-84.